Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.32
-0.4850-12.76%
Post-market: 3.30-0.0137-0.41%16:19 EDT
Volume:26.73M
Turnover:90.40M
Market Cap:1.75B
PE:-2.84
High:3.70
Open:3.63
Low:3.21
Close:3.80
52wk High:7.18
52wk Low:2.77
Shares:527.40M
Float Shares:415.00M
Volume Ratio:0.96
T/O Rate:6.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1684
EPS(LYR):-1.4410
ROE:-57.16%
ROA:-27.66%
PB:1.71
PE(LYR):-2.30

Loading ...

Jun 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 12, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
May 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 06, 2026

Major Issues Report

Form 8-K - Current report
May 06, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 30, 2026

Major Issues Report

Form 8-K - Current report
Apr 24, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Apr 22, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Apr 07, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 25, 2026

Major Issues Report

Form 8-K - Current report
Mar 23, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 09, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Mar 03, 2026

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS Director Borgeson Blake proposes to sell 170,000 shares, with a total value of approximately $588,200.
Feb 25, 2026

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans